ALK Chromosome 2

ALK receptor tyrosine kinase
365 variants 365 Health Risk

Upload your DNA to see your personal genotypes for variants in ALK.

What This Gene Does
This gene encodes a receptor tyrosine kinase, which belongs to the insulin receptor superfamily. This protein comprises an extracellular domain, an hydrophobic stretch corresponding to a single pass transmembrane region, and an intracellular kinase domain. It plays an important role in the development of the brain and exerts its effects on specific neurons in the nervous system. This gene has been found to be rearranged, mutated, or amplified in a series of tumours including anaplastic large cell lymphomas, neuroblastoma, and non-small cell lung cancer. The chromosomal rearrangements are the most common genetic alterations in this gene, which result in creation of multiple fusion genes in tumourigenesis, including ALK (chromosome 2)/EML4 (chromosome 2), ALK/RANBP2 (chromosome 2), ALK/ATIC (chromosome 2), ALK/TFG (chromosome 3), ALK/NPM1 (chromosome 5), ALK/SQSTM1 (chromosome 5), ALK/KIF5B (chromosome 10), ALK/CLTC (chromosome 17), ALK/TPM4 (chromosome 19), and ALK/MSN (chromosome X).[provided by RefSeq, Jan 2011]
Gene Info
Gene Group
"Receptor tyrosine kinases|CD molecules"
Locus Type
gene with protein product
Location
2p23.2-p23.1
Ensembl
ENSG00000171094
Associated Conditions (14)
Neuroblastoma
susceptibility to
3
Hereditary cancer-predisposing syndrome
Ovarian cancer
ALK-related disorder
Ovarian serous cystadenocarcinoma
Familial isolated pituitary adenoma
Diffuse midline glioma
H3 K27-altered
Malignant tumor of urinary bladder
Lung cancer
Rhabdomyosarcoma
Neoplasm
Key Variants
All Variants (365)
RSID Category Clinical Significance Conditions
RS2148258238 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS2148307303 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS2148442883 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS2148443048 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS2148443574 Health Risk Conflicting classifications of pathogenicity Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome
RS2148443715 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS2293564 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS2465426745 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS2465435723 Health Risk Conflicting classifications of pathogenicity Hereditary cancer-predisposing syndrome, Neuroblastoma, susceptibility to
RS2465864684 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS2465865784 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS2465866966 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS2465873305 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS34617074 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS35670445 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS367674546 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS367712624 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS368122868 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS368654781 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS369196372 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS369505500 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS370435082 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS370848188 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS371005946 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS371652715 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS371679329 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS371735276 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS372037531 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS372612147 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS373037272 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS373120394 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS374136388 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS374587233 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS375097381 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS375296866 Health Risk Conflicting classifications of pathogenicity Hereditary cancer-predisposing syndrome, Neuroblastoma, susceptibility to
RS375889530 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS376702277 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS377129811 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS377214413 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS528928041 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS531490912 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS532808222 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS536284304 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS539763601 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS541315214 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS542229113 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS544926207 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS550608288 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS554599505 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS55697431 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
Sign Up to Analyze Your DNA Log In